Abstract
The relationship of immunotherapy, seasonal pollen exposure and clinical results to serum total IgE and ragweed-specific IgE was studied in a group of 63 highly ragweed-sensitive individuals. Both immunological parameters rose after small doses of immunotherapy. After larger doses, IgE antibodies fell. Immunotherapy inhibited the seasonal rise in ragweed IgE antibodies, which occurs in nonimmunized patients. This decrease in IgE antibodies and inhibition of seasonal rise was associated with a good clinical response. This immunological pattern and concomitant successful clinical result appeared related to high-dose immunotherapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International archives of allergy and applied immunology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
